Stephen Clarke

Stephen Clarke

University of Sydney - Sydney / Australia
Medical and Health Sciences / Medical Oncology
AD Scientific Index ID: 1246
person_outline Stephen Clarke's MOST POPULAR ARTICLES
1-) Bevacizumab in combination with oxaliplatin-based chemotherapy as first-line therapy in metastatic colorectal cancer: a randomized phase III studyLB Saltz, S Clarke, E Díaz-Rubio, W Scheithauer, A Figer, R Wong, ...Journal of clinical oncology 26 (12), 2013-2019, 200836322008
2-) Cancer-related inflammation and treatment effectivenessCI Diakos, KA Charles, DC McMillan, SJ ClarkeThe Lancet Oncology 15 (11), e493-e503, 201413942014
3-) The systemic inflammation-based neutrophil–lymphocyte ratio: experience in patients with cancerGJK Guthrie, KA Charles, CSD Roxburgh, PG Horgan, DC McMillan, ...Critical reviews in oncology/hematology 88 (1), 218-230, 201313732013
4-) Randomized phase III study of capecitabine plus oxaliplatin compared with fluorouracil/folinic acid plus oxaliplatin as first-line therapy for metastatic colorectal cancerJ Cassidy, S Clarke, E Díaz-Rubio, W Scheithauer, A Figer, R Wong, ...Journal of clinical oncology 26 (12), 2006-2012, 200811432008
5-) Bevacizumab plus oxaliplatin-based chemotherapy as adjuvant treatment for colon cancer (AVANT): a phase 3 randomised controlled trialA De Gramont, E Van Cutsem, HJ Schmoll, J Tabernero, S Clarke, ...The lancet oncology 13 (12), 1225-1233, 20126582012